Neogen Corp
NEOG- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000711377
In the last 90 days, Neogen Corp insiders filed 1 open-market purchase and 0 sales; 316 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Neogen Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 309
- +13 vs. Q1 2021
- Shares held
- 100.0M
- +115.3K (+0.1%) vs. Q1 2021Converted for a 2-for-1 split
- Total value
- $4.60B
- +$167.3M (+3.8%) vs. Q1 2021
- New holders
- 38
- 88 more added
- Sold out
- 25
- 97 more reduced
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEOG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 316 | $2.13B |
| Q1 2026 | 308 | $2.16B |
| Q4 2025 | 306 | $1.56B |
| Q3 2025 | 300 | $1.36B |
| Q2 2025 | 317 | $1.15B |
| Q1 2025 | 340 | $2.37B |
| Q4 2024 | 344 | $3.15B |
| Q3 2024 | 338 | $4.27B |
| Q2 2024 | 346 | $3.93B |
| Q1 2024 | 344 | $3.78B |
| Q4 2023 | 341 | $4.66B |
| Q3 2023 | 367 | $4.12B |
| Q2 2023 | 342 | $4.99B |
| Q1 2023 | 355 | $4.12B |
| Q4 2022 | 371 | $3.30B |
| Q3 2022 | 386 | $2.91B |
| Q2 2022 | 311 | $2.52B |
| Q1 2022 | 318 | $3.15B |
| Q4 2021 | 322 | $4.54B |
| Q3 2021 | 304 | $4.32B |
| Q2 2021 | 309 | $4.60B |
| Q1 2021 | 298 | $4.43B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Neogen Corp; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Neuberger Berman Group LLC | 2,179,531 | $99.1M | 0.09% | −55,195−2.5% | ReducedConverted for a 2-for-1 split |
| Riverbridge Partners LLC | 2,802,535 | $129.0M | 1.31% | +116,913+4.4% | AddedConverted for a 2-for-1 split |
| State Street Corp | 3,453,526 | $159.0M | 0.01% | +55,366+1.6% | AddedConverted for a 2-for-1 split |
| Conestoga Capital Advisors, LLC | 3,741,391 | $172.3M | 2.49% | 00.0% | UnchangedConverted for a 2-for-1 split |
| Fred Alger Management, LLC | 4,860,420 | $223.8M | 0.53% | +575,132+13.4% | AddedConverted for a 2-for-1 split |
| Wasatch Advisors Inc | 7,186,021 | $330.8M | 1.34% | +616,789+9.4% | AddedConverted for a 2-for-1 split |
| Vanguard Group Inc | 10,661,153 | $490.8M | 0.01% | +59,491+0.6% | AddedConverted for a 2-for-1 split |
| BlackRock Inc. | 12,134,282 | $558.7M | 0.02% | −394,076−3.1% | ReducedConverted for a 2-for-1 split |
| Brown Capital Management LLC | 12,369,212 | $569.5M | 4.32% | −603,380−4.7% | ReducedConverted for a 2-for-1 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −233,042−100.0% | Sold outConverted for a 2-for-1 split |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −61,488−100.0% | Sold outConverted for a 2-for-1 split |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −53,792−100.0% | Sold outConverted for a 2-for-1 split |
| Foundry Partners, LLC | 0 | $0 | 0.00% | −44,294−100.0% | Sold outConverted for a 2-for-1 split |
| Mackay Shields LLC | 0 | $0 | 0.00% | −41,400−100.0% | Sold outConverted for a 2-for-1 split |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −33,514−100.0% | Sold outConverted for a 2-for-1 split |
| Aviva PLC | 0 | $0 | 0.00% | −27,956−100.0% | Sold outConverted for a 2-for-1 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,898−100.0% | Sold outConverted for a 2-for-1 split |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −16,294−100.0% | Sold outConverted for a 2-for-1 split |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −11,434−100.0% | Sold outConverted for a 2-for-1 split |
| Centiva Capital, LP | 0 | $0 | 0.00% | −9,670−100.0% | Sold outConverted for a 2-for-1 split |
| Greenleaf Trust | 0 | $0 | 0.00% | −5,422−100.0% | Sold outConverted for a 2-for-1 split |
| FORA Capital, LLC | 0 | $0 | 0.00% | −3,766−100.0% | Sold outConverted for a 2-for-1 split |
| Manchester Financial Inc | 0 | $0 | 0.00% | −2,250−100.0% | Sold outConverted for a 2-for-1 split |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −1,244−100.0% | Sold outConverted for a 2-for-1 split |
| RWM Asset Management, LLC | 0 | $0 | 0.00% | −1,048−100.0% | Sold outConverted for a 2-for-1 split |
| Archer Investment Corp | 0 | $0 | 0.00% | −494−100.0% | Sold outConverted for a 2-for-1 split |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −396−100.0% | Sold outConverted for a 2-for-1 split |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −332−100.0% | Sold outConverted for a 2-for-1 split |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −288−100.0% | Sold outConverted for a 2-for-1 split |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −226−100.0% | Sold outConverted for a 2-for-1 split |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold outConverted for a 2-for-1 split |
| Brand Asset Management Group, Inc. | 0 | $0 | 0.00% | −76−100.0% | Sold outConverted for a 2-for-1 split |
| Assetmark, Inc | 0 | $0 | 0.00% | −38−100.0% | Sold outConverted for a 2-for-1 split |
| WealthShield Partners, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold outConverted for a 2-for-1 split |
| TCF National Bank | – | – | – | – | Not filed |
| Tompkins Financial Corp | – | – | – | – | Not filed |